A synergistic metabolic blend combining Semaglutide and Cagrilintide for enhanced weight management. Semaglutide provides long-acting GLP-1 receptor agonism, while Cagrilintide enhances satiety and slows gastric emptying through amylin receptor activation. This combination offers superior appetite control and metabolic benefits.